- Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR MGH)
Do you think you might be at risk for diabetes?
Does anyone in your family have diabetes?
Are you overweight?
If you are interested in participating in a new research study…
We need your help!
The Center for Human Genetic Research at Massachusetts General Hospital seeks men and women over the age of 18 who are not currently on diabetes medication for a research study exploring the influence of genetic background on the response to established type 2 diabetes treatments.
Participants will be asked to visit the hospital twice in seven days.
The total time commitment is five hours for the first visit and three hours for the second visit.
Compensation will be provided up to $100 and a free meal.
Contact Sofia at (617)643-4985 or email aswarner@partners.org
Does anyone in your family have diabetes?
Are you overweight?
If you are interested in participating in a new research study…
We need your help!
The Center for Human Genetic Research at Massachusetts General Hospital seeks men and women over the age of 18 who are not currently on diabetes medication for a research study exploring the influence of genetic background on the response to established type 2 diabetes treatments.
Participants will be asked to visit the hospital twice in seven days.
The total time commitment is five hours for the first visit and three hours for the second visit.
Compensation will be provided up to $100 and a free meal.
Contact Sofia at (617)643-4985 or email aswarner@partners.org
Institution – MGH - Massachusetts General Hospital, Boston, MA
Principal Investigator – Jose C Florez, MD, PhD
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name – A. Sofia Warner
Email – aswarner@partners.org
Phone – (617)643-4985
About Type 2 Diabetes:
Type 2 diabetes is a metabolic disorder resulting from the body's inability to make enough, or to properly use, insulin. It used to be called non-insulin-dependent diabetes mellitus (NIDDM).
Without adequate production or utilization of insulin, the body cannot move blood sugar into the cells. It is a chronic disease that has no known cure. It is the most common type of diabetes, accounting for 90 to 95 percent of diabetes cases.
Type 2 diabetes is a metabolic disorder resulting from the body's inability to make enough, or to properly use, insulin. It used to be called non-insulin-dependent diabetes mellitus (NIDDM).
Without adequate production or utilization of insulin, the body cannot move blood sugar into the cells. It is a chronic disease that has no known cure. It is the most common type of diabetes, accounting for 90 to 95 percent of diabetes cases.
